RejuvaKnee Collagen Meniscus Implant
FDA 510(k) K242302 · Collagen Matrix, Inc.
Submission
- Device name
- RejuvaKnee Collagen Meniscus Implant
- Applicant
- Collagen Matrix, Inc.
Oakland, NJ, US - Received
- August 5, 2024
- Decision date
- October 2, 2024
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- OLC – Scaffold, Partial Medial Meniscal Defects Extending Into The Red/White Zone, Resorbable Bovine Collagen
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 878.3300
- Specialty
- General, Plastic Surgery
- Implant
- Yes
Intended for use in surgical procedures for the repair and reinforcement of soft tissue injuries of the medial meniscus. In repairing and reinforcing medial meniscal defects, the patient must have an intact meniscal rim and anterior and posterior horns for attachment of the mesh. In addition, the surgically prepared site must extend at least into the red/white zone of the meniscus to provide…
Other 510(k)s with product code OLC
More from Regen Biologics, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K251191 | Collagen Dura Regeneration Membrane - RepairGXQ · Traditional | 11/18/2025SE |
| K243071 | Bovine Dermis Collagen Dermal MatrixKGN · Traditional | 12/19/2024SE |
| K233203 | Soft Tissue Augmentation Resorbable MatrixNPL · Traditional | 05/01/2024SE |
| K240424 | Mineral Collagen Composite Bioactive Moldable Bone Graft MatrixMQV · Traditional | 03/12/2024SE |
| K231942 | Mineral Collagen Composite Bioactive Extra MoldableMQV · Special | 08/02/2023SE |
| K221735 | Mineral Collagen Composite Bioactive MoldableMQV · Traditional | 12/20/2022SE |
| K213341 | Fibrillar Collagen Wound DressingKGN · Traditional | 05/31/2022SE |
| K202183 | Porcine Mineral Collagen CompositeNPM · Traditional | 04/02/2021SE |
| K201859 | Porcine Mineral Collagen Composite MoldableNPM · Traditional | 09/11/2020SE |
| K182074 | Mineral Collagen Composite Bioactive MoldableMQV · Traditional | 03/21/2019SE |
Questions and answers
When was RejuvaKnee Collagen Meniscus Implant cleared by the FDA?
RejuvaKnee Collagen Meniscus Implant (K242302) received a 510(k) decision of Substantially Equivalent on October 2, 2024, 58 days after the submission was received.
What is the product code of K242302?
The FDA product code is OLC – Scaffold, Partial Medial Meniscal Defects Extending Into The Red/White Zone, Resorbable Bovine Collagen, a Class II (moderate risk) device regulated under 21 CFR 878.3300.